Are you over 18 and want to see adult content?
More Annotations
A complete backup of fiestapoolsandspas.com
Are you over 18 and want to see adult content?
A complete backup of checkpancard.com
Are you over 18 and want to see adult content?
A complete backup of erichutchinson.com
Are you over 18 and want to see adult content?
A complete backup of mk-haustechnik.hu
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of createapeacefulhome.com
Are you over 18 and want to see adult content?
A complete backup of white-dicks-in-white-chicks.tumblr.com
Are you over 18 and want to see adult content?
A complete backup of avaloncakesschool.com
Are you over 18 and want to see adult content?
A complete backup of hyenascomedynightclub.com
Are you over 18 and want to see adult content?
Text
More »
DPAC CHAMPIONS
Looking for more than simply clicking a link and sending a message to policy makers? Want to get more involved with diabetes policy advocacy and become a trusted patient voice on policy issues impacting people in the United States? Have a desire to get more training, do more be more for our patient community? The DPAC CHAMPIONS Read More » AFFORDABLE INSULIN PROJECT Affordable Insulin Project We believe that all Americans with diabetes should have affordable access to insulin. We believe that patients must be an integral part of the discussion at every step of the supply chain, from manufacturers and employers to Pharmaceutical Benefits Managers (PBMs) and the government. The Affordable Insulin Project offers tools, resources, and AFFORDABLE INSULINBLOG | DPAC
FOR IMMEDIATE RELEASE Lexington, Kentucky, Dec. 9, 2019 – DPAC today announced the appointment of Julie Babbage, of Babbage Cofounder asthe new CEO.
WHAT IS THE DIABETES CAUCUS? Did you know that there is a Congressional Diabetes Caucus? In this brief introductory post, you’ll learn what it is, who is involved, and why it matters to the diabetes community. What is a Caucus? A caucus is made up of individuals that share common legislative goals and initiatives. The Diabetes Caucus is, therefore, a group of What is the Diabetes Caucus? Read More » KNOW YOUR ISSUE: SPREAD PRICING In Ohio, where (reminder) PBMs charged Medicaid not only a nearly 9% spread across all drugs, but also a whopping 31% spread among generic drug prescriptions, the state’s Medicaid Director barred managed care plans from contracting with PBMs that engage in spread pricing. Instead, the state is allowing contracts that have “pass-through” pricing, where PBMs receive a flat administrative HOW AN IDEA BECOMES A STATE LAW HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must ADVOCACY 101: WRITING AN EFFECTIVE OP-ED WHY I ADVOCATE: MOIRA MCCARTHY STANFORD We asked our Patient Advisory Board members to share why they advocate, and what makes them passionate about diabetes advocacy. Moira McCarthy shared a memory of her daughter when she was young, and how that memory still motivates Moira to this day. HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
DPAC CHAMPIONS
Looking for more than simply clicking a link and sending a message to policy makers? Want to get more involved with diabetes policy advocacy and become a trusted patient voice on policy issues impacting people in the United States? Have a desire to get more training, do more be more for our patient community? The DPAC CHAMPIONS Read More » AFFORDABLE INSULIN PROJECT Affordable Insulin Project We believe that all Americans with diabetes should have affordable access to insulin. We believe that patients must be an integral part of the discussion at every step of the supply chain, from manufacturers and employers to Pharmaceutical Benefits Managers (PBMs) and the government. The Affordable Insulin Project offers tools, resources, and AFFORDABLE INSULINBLOG | DPAC
FOR IMMEDIATE RELEASE Lexington, Kentucky, Dec. 9, 2019 – DPAC today announced the appointment of Julie Babbage, of Babbage Cofounder asthe new CEO.
WHAT IS THE DIABETES CAUCUS? Did you know that there is a Congressional Diabetes Caucus? In this brief introductory post, you’ll learn what it is, who is involved, and why it matters to the diabetes community. What is a Caucus? A caucus is made up of individuals that share common legislative goals and initiatives. The Diabetes Caucus is, therefore, a group of What is the Diabetes Caucus? Read More » KNOW YOUR ISSUE: SPREAD PRICING In Ohio, where (reminder) PBMs charged Medicaid not only a nearly 9% spread across all drugs, but also a whopping 31% spread among generic drug prescriptions, the state’s Medicaid Director barred managed care plans from contracting with PBMs that engage in spread pricing. Instead, the state is allowing contracts that have “pass-through” pricing, where PBMs receive a flat administrative HOW AN IDEA BECOMES A STATE LAW HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must ADVOCACY 101: WRITING AN EFFECTIVE OP-ED WHY I ADVOCATE: MOIRA MCCARTHY STANFORD We asked our Patient Advisory Board members to share why they advocate, and what makes them passionate about diabetes advocacy. Moira McCarthy shared a memory of her daughter when she was young, and how that memory still motivates Moira to this day.ABOUT - DPAC
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care forBLOG | DPAC
FOR IMMEDIATE RELEASE Lexington, Kentucky, Dec. 9, 2019 – DPAC today announced the appointment of Julie Babbage, of Babbage Cofounder asthe new CEO.
HOW TO ADVOCATE
Want to advocate for the over 30 million American families who live with diabetes everyday? It’s not as hard as you think. DPAC can help. Follow the steps to explore the issues, take action, and raise your voice alongside other DPAC advocates. Step 1: Sign up for DPAC news. DPAC Newsletter No spam. We don’t HOW TO ADVOCATE Read More » FORCED NON-MEDICAL SWITCHING AND WHY IT'S HURTING PEOPLE Christopher G. Parkin is President of CGParkin Communications, Inc., a consulting firm that specializes in diabetes education development. During the past 30 years, Chris has authored numerous articles on diabetes technology and management and has assisted several medical organizations in the development of clinical practice guidelines, position statements and consensus conference reports ACCESS TO QUALITY DIABETES EDUCATION ACT NOW: Save lives and reduce cost with broader access to educators. One policy step to reducing the burden of diabetes, improving health outcomes and lowering costs is improved access to diabetes education. ACCUMULATOR ADJUSTMENT PROGRAMS PUT ADDED BURDEN ON PEOPLE Accumulator adjustment programs, or copay adjustment programs, are when insurance companies do not apply what the manufacturer pays when you use a copay card towards your deductible. These programs could cost people with diabetes thousands of dollars each year. PATIENT ADVISORY COUNCIL The members of the Patient Advisory Council (PAC) act as trusted spokespeople in all of DPAC’s advocacy efforts, promote DPAC’s mission within their communities, share their policy training skills, and much more. Erin Bubb 2018 – 2019 Rachel Gartner Clark 2019 Daphne Ferdinand 2019 Jen Hamm 2019 2020 DPAC Patient Advisory Council Laurel Garrison Co-Chair PATIENT ADVISORY COUNCIL Read BILLS-TO-LAWS: CHANGING FEDERAL DIABETES HEALTH POLICY We wish it were as simple as a cartoon, but it’s not. The bills-to-laws process is a vital part of policy-making and policy changing within the U.S. government. However, the legislative branch of the Congress, consisting of the House of Representatives and Senate, will see thousands of bills introduced in this 115 th United States Congress. Only 10% of these bills will become laws and make PHARMACY BENEFIT MANAGER (PBM) GAG CLAUSES TIE PHARMACISTS Gag clauses in contracts with pharmacy benefit managers (PBMs) prevent pharmacists from telling the truth about the price of some medications. The result of these gag clauses is higher costs for the unknowing patient. Find out who is taking action and write a lettertoday!
DIABETESPAC.ORG
301 Moved Permanently. nginx HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
AFFORDABLE INSULIN PROJECT The Affordable Insulin Project offers tools, resources, and data so that people impacted by today’s rising health care costs can positively influence the affordable access to this life essential drug. Whether you are a patient, family member, employer, or healthcare professional, you can spark a conversation. HOW AN IDEA BECOMES A STATE LAWDPAC CHAMPIONS
DPAC Policy Training Meetings will take place three times in D.C. in 2019. In order to ensure you don't miss the deadline, we'll send you a notification with the link when the application period opens! We never sell or rent our email addresses and you can unsubscribe at any time.Welcome!
LEADERSHIP | DPAC
DPAC LEADERSHIP George Huntley – CEO George is a founding member of the Diabetes Leadership Council (DLC) and currently serves as the CEO of both DPAC and DLC. He has been living with type 1 diabetes since 1983 and has 3 other family members also living with type 1. A passionate advocate for people with diabetes, LEADERSHIP Read More » HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must KNOW YOUR ISSUE: SPREAD PRICING Of the $2.5 billion, nearly $225 million was generated through spread pricing, including $208 million from prescriptions for generics.”. In Kentucky, a February report showed that PBMs earned more than $123 million in spread pricing in 2018, an increase of nearly 13% over 2017. With Medicaid programs representing a larger and larger portion ADVOCACY 101: WRITING AN EFFECTIVE OP-ED WHY I ADVOCATE: MOIRA MCCARTHY STANFORD Moira McCarthy Stanford. Moira McCarthy has been an active advocate in the diabetes space since shortly after her then six-year- old daughter, Lauren Stanford, was diagnosed with Type 1 Diabetes in 1997. Since they she has served as National Chair of Grass Roots Advocacy for JDRF, ChairMom of JDRF’s Children’s Congress, and was namedJDRF
CVS CAREMARK FORMULARY CHANGE MAKES MANY PATIENTS SWITCHSEE MORE ONDIABETESPAC.ORG
HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
AFFORDABLE INSULIN PROJECT The Affordable Insulin Project offers tools, resources, and data so that people impacted by today’s rising health care costs can positively influence the affordable access to this life essential drug. Whether you are a patient, family member, employer, or healthcare professional, you can spark a conversation. HOW AN IDEA BECOMES A STATE LAWDPAC CHAMPIONS
DPAC Policy Training Meetings will take place three times in D.C. in 2019. In order to ensure you don't miss the deadline, we'll send you a notification with the link when the application period opens! We never sell or rent our email addresses and you can unsubscribe at any time.Welcome!
HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must KNOW YOUR ISSUE: SPREAD PRICING Of the $2.5 billion, nearly $225 million was generated through spread pricing, including $208 million from prescriptions for generics.”. In Kentucky, a February report showed that PBMs earned more than $123 million in spread pricing in 2018, an increase of nearly 13% over 2017. With Medicaid programs representing a larger and larger portion WHAT IS THE DIABETES CAUCUS? What is a Caucus? A caucus is made up of individuals that share common legislative goals and initiatives. The Diabetes Caucus is, therefore, a group of Congress members who share the common goal of supporting legislation to benefit people with diabetes. Comprised of the House Diabetes Caucus and Senate Diabetes Caucus, the primary focus of the ADVOCACY 101: WRITING AN EFFECTIVE OP-ED WHY I ADVOCATE: MOIRA MCCARTHY STANFORD Moira McCarthy Stanford. Moira McCarthy has been an active advocate in the diabetes space since shortly after her then six-year- old daughter, Lauren Stanford, was diagnosed with Type 1 Diabetes in 1997. Since they she has served as National Chair of Grass Roots Advocacy for JDRF, ChairMom of JDRF’s Children’s Congress, and was namedJDRF
ANTHEM RESPONDS TO #DIABETESACCESSMATTERS Anthem Responds to #DiabetesAccessMatters. July 14, 2016. A DPAC Insider shared that Anthem, one of the companies receiving emails about the importance of access to prescribed diabetes treatments, has responded. Dr. John S. Yao, M.D., M.P.H., F.A.C.P, the Staff VP Medical Policy Development, Office of Medical Policy & TechnologyAssessment
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care forRESOURCES | DPAC
Resources As a trusted voice in the diabetes community, we want to provide the right resources in the areas of safety, quality, and access for people with diabetes. While this is by no means a comprehensive list, we hope that this will help. Diabetes Non Profit Organizations ADA Click Here AACE Click Here AADE Click RESOURCES ReadMore »
HOW TO ADVOCATE
Want to advocate for the over 30 million American families who live with diabetes everyday? It’s not as hard as you think. DPAC can help. Follow the steps to explore the issues, take action, and raise your voice alongside other DPAC advocates. Step 1: Sign up for DPAC news. DPAC Newsletter No spam. We don’t HOW TO ADVOCATE Read More »HOT ISSUES | DPAC
Instead of saving money and ensuring people with diabetes got access to trusted supplies, studies found that there were increased hospitalizations, increased costs for patients, and sadly, increased mortality in the test markets in the program. DPAC believes that CMS must exempt diabetes testing supplies from the CBP until they canemploy
ACCESS TO QUALITY DIABETES EDUCATION Diabetes education can be enhanced by increasing the pool of providers and bringing the benefit in line with new recommendations on critical times for diabetes education. Ask your Congress Members to support Access to Quality Diabetes Education Act of 2015 (S. 1345 / HR 1726). It is one policy step to reducing the burden of diabetes, improvingLEADERSHIP | DPAC
DPAC LEADERSHIP George Huntley – CEO George is a founding member of the Diabetes Leadership Council (DLC) and currently serves as the CEO of both DPAC and DLC. He has been living with type 1 diabetes since 1983 and has 3 other family members also living with type 1. A passionate advocate for people with diabetes, LEADERSHIP Read More » PATIENT ADVISORY COUNCIL The members of the Patient Advisory Council (PAC) act as trusted spokespeople in all of DPAC’s advocacy efforts, promote DPAC’s mission within their communities, share their policy training skills, and much more. Erin Bubb 2018 – 2019 Rachel Gartner Clark 2019 Daphne Ferdinand 2019 Jen Hamm 2019 2020 DPAC Patient Advisory Council Laurel Garrison Co-Chair PATIENT ADVISORY COUNCIL Read ACCUMULATOR ADJUSTMENT PROGRAMS PUT ADDED BURDEN ON PEOPLE Accumulator adjustment programs, or copay adjustment programs, are when insurance companies do not apply what the manufacturer pays when you use a copay card towards your deductible. These programs could cost people with diabetes thousands of dollars each year. BILLS-TO-LAWS: CHANGING FEDERAL DIABETES HEALTH POLICY The bills-to-laws process is a vital part of policy-making and policy changing within the U.S. government. However, the legislative branch of the Congress, consisting of the House of Representatives and Senate, will see thousands of bills introduced in this 115 th United States Congress. Only 10% of these bills will become laws and make it PHARMACY BENEFIT MANAGER (PBM) GAG CLAUSES TIE PHARMACISTS Gag clauses in contracts with pharmacy benefit managers (PBMs) prevent pharmacists from telling the truth about the price of some medications. The result of these gag clauses is higher costs for the unknowing patient. Find out who is taking action and write a lettertoday!
HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
PROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care for HOW AN IDEA BECOMES A STATE LAW AFFORDABLE INSULIN PROJECT The Affordable Insulin Project offers tools, resources, and data so that people impacted by today’s rising health care costs can positively influence the affordable access to this life essential drug. Whether you are a patient, family member, employer, or healthcare professional, you can spark a conversation.HOT ISSUES | DPAC
Instead of saving money and ensuring people with diabetes got access to trusted supplies, studies found that there were increased hospitalizations, increased costs for patients, and sadly, increased mortality in the test markets in the program. DPAC believes that CMS must exempt diabetes testing supplies from the CBP until they canemploy
DPAC CHAMPIONS
DPAC Policy Training Meetings will take place three times in D.C. in 2019. In order to ensure you don't miss the deadline, we'll send you a notification with the link when the application period opens! We never sell or rent our email addresses and you can unsubscribe at any time.Welcome!
HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must KNOW YOUR ISSUE: SPREAD PRICING Of the $2.5 billion, nearly $225 million was generated through spread pricing, including $208 million from prescriptions for generics.”. In Kentucky, a February report showed that PBMs earned more than $123 million in spread pricing in 2018, an increase of nearly 13% over 2017. With Medicaid programs representing a larger and larger portion ADVOCACY 101: WRITING AN EFFECTIVE OP-ED HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
PROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care for HOW AN IDEA BECOMES A STATE LAW AFFORDABLE INSULIN PROJECT The Affordable Insulin Project offers tools, resources, and data so that people impacted by today’s rising health care costs can positively influence the affordable access to this life essential drug. Whether you are a patient, family member, employer, or healthcare professional, you can spark a conversation.HOT ISSUES | DPAC
Instead of saving money and ensuring people with diabetes got access to trusted supplies, studies found that there were increased hospitalizations, increased costs for patients, and sadly, increased mortality in the test markets in the program. DPAC believes that CMS must exempt diabetes testing supplies from the CBP until they canemploy
DPAC CHAMPIONS
DPAC Policy Training Meetings will take place three times in D.C. in 2019. In order to ensure you don't miss the deadline, we'll send you a notification with the link when the application period opens! We never sell or rent our email addresses and you can unsubscribe at any time.Welcome!
HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must KNOW YOUR ISSUE: SPREAD PRICING Of the $2.5 billion, nearly $225 million was generated through spread pricing, including $208 million from prescriptions for generics.”. In Kentucky, a February report showed that PBMs earned more than $123 million in spread pricing in 2018, an increase of nearly 13% over 2017. With Medicaid programs representing a larger and larger portion ADVOCACY 101: WRITING AN EFFECTIVE OP-EDPROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care forHOW TO ADVOCATE
Want to advocate for the over 30 million American families who live with diabetes everyday? It’s not as hard as you think. DPAC can help. Follow the steps to explore the issues, take action, and raise your voice alongside other DPAC advocates.CONTACT US | DPAC
Contact Form Please email us for the fastest response. Address 12157 West Linebaugh Ave, Suite 141 Tampa, FL 33626 Email info@diabetespac.orgSTATE - HOME
New York Emergency Glucagon in NY Schools – S8995 New York students with diabetes need access to glucagon in schools and trained professionals to help administer glucagon in emergencies. Click below to advocate for S8995 to increase safety for students with diabetes. Click Here California Ask California Assembly to Support Type 1 Educational Notification in STATE Read More »HOT ISSUES | DPAC
Non-medical switching negatively impacts patients by disrupting their care and does not generate cost savings for the patient or the insurer. Forced non-medical switching can happen in one of two ways: The insurer stops covering the medication or medical device, forcing patients to pay out-of-pocket for the medication/device that is already working well for them.EVENTS | DPAC
Events Friends for Life SeattleMarch 29-31, 2019 Join DPAC at the policy advocacy sessions when you register for Friends for Life in Seattle. Click Here to Learn More DPAC Policy Training Meeting April 30 – May 2, 2019 Interested in becoming a DPAC Champion and advocating on Capitol Hill in D.C.? Click Here to Learn EVENTS ReadMore »
FORCED NON-MEDICAL SWITCHING AND WHY IT'S HURTING PEOPLE Forced non-medical switching can happen in one of two ways: The insurer stops covering the medication or medical device, forcing patients to pay out-of-pocket for the medication/device that is already working well for them. The insurer increases patient co-pays, resulting in additional financial hardship for a disease that is already too expensive. WHY I ADVOCATE: MOIRA MCCARTHY STANFORD Moira McCarthy Stanford. Moira McCarthy has been an active advocate in the diabetes space since shortly after her then six-year- old daughter, Lauren Stanford, was diagnosed with Type 1 Diabetes in 1997. Since they she has served as National Chair of Grass Roots Advocacy for JDRF, ChairMom of JDRF’s Children’s Congress, and was namedJDRF
ANTHEM RESPONDS TO #DIABETESACCESSMATTERS Anthem Responds to #DiabetesAccessMatters. July 14, 2016. A DPAC Insider shared that Anthem, one of the companies receiving emails about the importance of access to prescribed diabetes treatments, has responded. Dr. John S. Yao, M.D., M.P.H., F.A.C.P, the Staff VP Medical Policy Development, Office of Medical Policy & TechnologyAssessment
HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
PROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care for HOW AN IDEA BECOMES A STATE LAW AFFORDABLE INSULIN PROJECT The Affordable Insulin Project offers tools, resources, and data so that people impacted by today’s rising health care costs can positively influence the affordable access to this life essential drug. Whether you are a patient, family member, employer, or healthcare professional, you can spark a conversation.HOT ISSUES | DPAC
Instead of saving money and ensuring people with diabetes got access to trusted supplies, studies found that there were increased hospitalizations, increased costs for patients, and sadly, increased mortality in the test markets in the program. DPAC believes that CMS must exempt diabetes testing supplies from the CBP until they canemploy
DPAC CHAMPIONS
DPAC Policy Training Meetings will take place three times in D.C. in 2019. In order to ensure you don't miss the deadline, we'll send you a notification with the link when the application period opens! We never sell or rent our email addresses and you can unsubscribe at any time.Welcome!
HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must KNOW YOUR ISSUE: SPREAD PRICING Of the $2.5 billion, nearly $225 million was generated through spread pricing, including $208 million from prescriptions for generics.”. In Kentucky, a February report showed that PBMs earned more than $123 million in spread pricing in 2018, an increase of nearly 13% over 2017. With Medicaid programs representing a larger and larger portion ADVOCACY 101: WRITING AN EFFECTIVE OP-ED HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
PROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care for HOW AN IDEA BECOMES A STATE LAW AFFORDABLE INSULIN PROJECT The Affordable Insulin Project offers tools, resources, and data so that people impacted by today’s rising health care costs can positively influence the affordable access to this life essential drug. Whether you are a patient, family member, employer, or healthcare professional, you can spark a conversation.HOT ISSUES | DPAC
Instead of saving money and ensuring people with diabetes got access to trusted supplies, studies found that there were increased hospitalizations, increased costs for patients, and sadly, increased mortality in the test markets in the program. DPAC believes that CMS must exempt diabetes testing supplies from the CBP until they canemploy
DPAC CHAMPIONS
DPAC Policy Training Meetings will take place three times in D.C. in 2019. In order to ensure you don't miss the deadline, we'll send you a notification with the link when the application period opens! We never sell or rent our email addresses and you can unsubscribe at any time.Welcome!
HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must KNOW YOUR ISSUE: SPREAD PRICING Of the $2.5 billion, nearly $225 million was generated through spread pricing, including $208 million from prescriptions for generics.”. In Kentucky, a February report showed that PBMs earned more than $123 million in spread pricing in 2018, an increase of nearly 13% over 2017. With Medicaid programs representing a larger and larger portion ADVOCACY 101: WRITING AN EFFECTIVE OP-EDPROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care forHOW TO ADVOCATE
Want to advocate for the over 30 million American families who live with diabetes everyday? It’s not as hard as you think. DPAC can help. Follow the steps to explore the issues, take action, and raise your voice alongside other DPAC advocates.CONTACT US | DPAC
Contact Form Please email us for the fastest response. Address 12157 West Linebaugh Ave, Suite 141 Tampa, FL 33626 Email info@diabetespac.orgSTATE - HOME
New York Emergency Glucagon in NY Schools – S8995 New York students with diabetes need access to glucagon in schools and trained professionals to help administer glucagon in emergencies. Click below to advocate for S8995 to increase safety for students with diabetes. Click Here California Ask California Assembly to Support Type 1 Educational Notification in STATE Read More »HOT ISSUES | DPAC
Non-medical switching negatively impacts patients by disrupting their care and does not generate cost savings for the patient or the insurer. Forced non-medical switching can happen in one of two ways: The insurer stops covering the medication or medical device, forcing patients to pay out-of-pocket for the medication/device that is already working well for them.EVENTS | DPAC
Events Friends for Life SeattleMarch 29-31, 2019 Join DPAC at the policy advocacy sessions when you register for Friends for Life in Seattle. Click Here to Learn More DPAC Policy Training Meeting April 30 – May 2, 2019 Interested in becoming a DPAC Champion and advocating on Capitol Hill in D.C.? Click Here to Learn EVENTS ReadMore »
FORCED NON-MEDICAL SWITCHING AND WHY IT'S HURTING PEOPLE Forced non-medical switching can happen in one of two ways: The insurer stops covering the medication or medical device, forcing patients to pay out-of-pocket for the medication/device that is already working well for them. The insurer increases patient co-pays, resulting in additional financial hardship for a disease that is already too expensive. WHY I ADVOCATE: MOIRA MCCARTHY STANFORD Moira McCarthy Stanford. Moira McCarthy has been an active advocate in the diabetes space since shortly after her then six-year- old daughter, Lauren Stanford, was diagnosed with Type 1 Diabetes in 1997. Since they she has served as National Chair of Grass Roots Advocacy for JDRF, ChairMom of JDRF’s Children’s Congress, and was namedJDRF
ANTHEM RESPONDS TO #DIABETESACCESSMATTERS Anthem Responds to #DiabetesAccessMatters. July 14, 2016. A DPAC Insider shared that Anthem, one of the companies receiving emails about the importance of access to prescribed diabetes treatments, has responded. Dr. John S. Yao, M.D., M.P.H., F.A.C.P, the Staff VP Medical Policy Development, Office of Medical Policy & TechnologyAssessment
HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
PROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care for HOW AN IDEA BECOMES A STATE LAW AFFORDABLE INSULIN PROJECT The Affordable Insulin Project offers tools, resources, and data so that people impacted by today’s rising health care costs can positively influence the affordable access to this life essential drug. Whether you are a patient, family member, employer, or healthcare professional, you can spark a conversation.HOT ISSUES | DPAC
Instead of saving money and ensuring people with diabetes got access to trusted supplies, studies found that there were increased hospitalizations, increased costs for patients, and sadly, increased mortality in the test markets in the program. DPAC believes that CMS must exempt diabetes testing supplies from the CBP until they canemploy
DPAC CHAMPIONS
DPAC Policy Training Meetings will take place three times in D.C. in 2019. In order to ensure you don't miss the deadline, we'll send you a notification with the link when the application period opens! We never sell or rent our email addresses and you can unsubscribe at any time.Welcome!
HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must KNOW YOUR ISSUE: SPREAD PRICING Of the $2.5 billion, nearly $225 million was generated through spread pricing, including $208 million from prescriptions for generics.”. In Kentucky, a February report showed that PBMs earned more than $123 million in spread pricing in 2018, an increase of nearly 13% over 2017. With Medicaid programs representing a larger and larger portion ADVOCACY 101: WRITING AN EFFECTIVE OP-ED HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
PROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care for HOW AN IDEA BECOMES A STATE LAW AFFORDABLE INSULIN PROJECT The Affordable Insulin Project offers tools, resources, and data so that people impacted by today’s rising health care costs can positively influence the affordable access to this life essential drug. Whether you are a patient, family member, employer, or healthcare professional, you can spark a conversation.HOT ISSUES | DPAC
Instead of saving money and ensuring people with diabetes got access to trusted supplies, studies found that there were increased hospitalizations, increased costs for patients, and sadly, increased mortality in the test markets in the program. DPAC believes that CMS must exempt diabetes testing supplies from the CBP until they canemploy
DPAC CHAMPIONS
DPAC Policy Training Meetings will take place three times in D.C. in 2019. In order to ensure you don't miss the deadline, we'll send you a notification with the link when the application period opens! We never sell or rent our email addresses and you can unsubscribe at any time.Welcome!
HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must KNOW YOUR ISSUE: SPREAD PRICING Of the $2.5 billion, nearly $225 million was generated through spread pricing, including $208 million from prescriptions for generics.”. In Kentucky, a February report showed that PBMs earned more than $123 million in spread pricing in 2018, an increase of nearly 13% over 2017. With Medicaid programs representing a larger and larger portion ADVOCACY 101: WRITING AN EFFECTIVE OP-EDPROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care forHOW TO ADVOCATE
Want to advocate for the over 30 million American families who live with diabetes everyday? It’s not as hard as you think. DPAC can help. Follow the steps to explore the issues, take action, and raise your voice alongside other DPAC advocates.CONTACT US | DPAC
Contact Form Please email us for the fastest response. Address 12157 West Linebaugh Ave, Suite 141 Tampa, FL 33626 Email info@diabetespac.orgSTATE - HOME
New York Emergency Glucagon in NY Schools – S8995 New York students with diabetes need access to glucagon in schools and trained professionals to help administer glucagon in emergencies. Click below to advocate for S8995 to increase safety for students with diabetes. Click Here California Ask California Assembly to Support Type 1 Educational Notification in STATE Read More »HOT ISSUES | DPAC
Non-medical switching negatively impacts patients by disrupting their care and does not generate cost savings for the patient or the insurer. Forced non-medical switching can happen in one of two ways: The insurer stops covering the medication or medical device, forcing patients to pay out-of-pocket for the medication/device that is already working well for them.EVENTS | DPAC
Events Friends for Life SeattleMarch 29-31, 2019 Join DPAC at the policy advocacy sessions when you register for Friends for Life in Seattle. Click Here to Learn More DPAC Policy Training Meeting April 30 – May 2, 2019 Interested in becoming a DPAC Champion and advocating on Capitol Hill in D.C.? Click Here to Learn EVENTS ReadMore »
FORCED NON-MEDICAL SWITCHING AND WHY IT'S HURTING PEOPLE Forced non-medical switching can happen in one of two ways: The insurer stops covering the medication or medical device, forcing patients to pay out-of-pocket for the medication/device that is already working well for them. The insurer increases patient co-pays, resulting in additional financial hardship for a disease that is already too expensive. WHY I ADVOCATE: MOIRA MCCARTHY STANFORD Moira McCarthy Stanford. Moira McCarthy has been an active advocate in the diabetes space since shortly after her then six-year- old daughter, Lauren Stanford, was diagnosed with Type 1 Diabetes in 1997. Since they she has served as National Chair of Grass Roots Advocacy for JDRF, ChairMom of JDRF’s Children’s Congress, and was namedJDRF
ANTHEM RESPONDS TO #DIABETESACCESSMATTERS Anthem Responds to #DiabetesAccessMatters. July 14, 2016. A DPAC Insider shared that Anthem, one of the companies receiving emails about the importance of access to prescribed diabetes treatments, has responded. Dr. John S. Yao, M.D., M.P.H., F.A.C.P, the Staff VP Medical Policy Development, Office of Medical Policy & TechnologyAssessment
HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
PROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care forHOW TO ADVOCATE
Want to advocate for the over 30 million American families who live with diabetes everyday? It’s not as hard as you think. DPAC can help. Follow the steps to explore the issues, take action, and raise your voice alongside other DPAC advocates. Step 1: Sign up for DPAC news. DPAC Newsletter No spam. We don’t HOW TO ADVOCATE Read More » AFFORDABLE INSULIN PROJECT Affordable Insulin Project We believe that all Americans with diabetes should have affordable access to insulin. We believe that patients must be an integral part of the discussion at every step of the supply chain, from manufacturers and employers to Pharmaceutical Benefits Managers (PBMs) and the government. The Affordable Insulin Project offers tools, resources, and AFFORDABLE INSULINDPAC CHAMPIONS
Looking for more than simply clicking a link and sending a message to policy makers? Want to get more involved with diabetes policy advocacy and become a trusted patient voice on policy issues impacting people in the United States? Have a desire to get more training, do more be more for our patient community? The DPAC CHAMPIONS Read More » HOW AN IDEA BECOMES A STATE LAW KNOW YOUR ISSUE: SPREAD PRICING Pharmacy Benefit Managers (PBMs) are good at making something out of nothing. We’ve seen them turn a profit through drug rebates, accumulator adjustment programs, clawbacks, and more.The Centers for Medicare and Medicaid Services (CMS) recently issued a guidance on spread pricing, but states have been dealing with this issue for a while now. A Brief Explanation of Spread HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must ADVOCACY 101: WRITING AN EFFECTIVE OP-ED HOME | DPACACT NOWEXPLOREPROGRAMSRESOURCESBLOGABOUT Click Here Click Here to Send a Letter to Your State Leadership!Is your representative a member of the Congressional Diabetes Caucus?Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click HereAdvocate for insulin exemption from your high deductible HOME ReadMore »
PROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care forHOW TO ADVOCATE
Want to advocate for the over 30 million American families who live with diabetes everyday? It’s not as hard as you think. DPAC can help. Follow the steps to explore the issues, take action, and raise your voice alongside other DPAC advocates. Step 1: Sign up for DPAC news. DPAC Newsletter No spam. We don’t HOW TO ADVOCATE Read More » AFFORDABLE INSULIN PROJECT Affordable Insulin Project We believe that all Americans with diabetes should have affordable access to insulin. We believe that patients must be an integral part of the discussion at every step of the supply chain, from manufacturers and employers to Pharmaceutical Benefits Managers (PBMs) and the government. The Affordable Insulin Project offers tools, resources, and AFFORDABLE INSULINDPAC CHAMPIONS
Looking for more than simply clicking a link and sending a message to policy makers? Want to get more involved with diabetes policy advocacy and become a trusted patient voice on policy issues impacting people in the United States? Have a desire to get more training, do more be more for our patient community? The DPAC CHAMPIONS Read More » HOW AN IDEA BECOMES A STATE LAW KNOW YOUR ISSUE: SPREAD PRICING Pharmacy Benefit Managers (PBMs) are good at making something out of nothing. We’ve seen them turn a profit through drug rebates, accumulator adjustment programs, clawbacks, and more.The Centers for Medicare and Medicaid Services (CMS) recently issued a guidance on spread pricing, but states have been dealing with this issue for a while now. A Brief Explanation of Spread HOW THE FDA DRUG APPROVAL PROCESS WORKS The FDA Drug Approval Process . The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must ADVOCACY 101: WRITING AN EFFECTIVE OP-EDPROGRAMS | DPAC
DPAC advocates receive calls to action and updates on issues impacting Congress and your state. We do not rent or sell your email address.Ever.
ABOUT - HOME
The Diabetes Patient Advocacy Coalition is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care forHOW TO ADVOCATE
Want to advocate for the over 30 million American families who live with diabetes everyday? It’s not as hard as you think. DPAC can help. Follow the steps to explore the issues, take action, and raise your voice alongside other DPAC advocates.CONTACT US | DPAC
Contact Form Please email us for the fastest response. Address 12157 West Linebaugh Ave, Suite 141 Tampa, FL 33626 Email info@diabetespac.orgSTATE - HOME
New York Emergency Glucagon in NY Schools – S8995 New York students with diabetes need access to glucagon in schools and trained professionals to help administer glucagon in emergencies. Click below to advocate for S8995 to increase safety for students with diabetes. Click Here California Ask California Assembly to Support Type 1 Educational Notification in STATE Read More »HOT ISSUES | DPAC
Non-medical switching negatively impacts patients by disrupting their care and does not generate cost savings for the patient or the insurer. Forced non-medical switching can happen in one of two ways: The insurer stops covering the medication or medical device, forcing patients to pay out-of-pocket for the medication/device that is already working well for them.EVENTS | DPAC
Events Friends for Life SeattleMarch 29-31, 2019 Join DPAC at the policy advocacy sessions when you register for Friends for Life in Seattle. Click Here to Learn More DPAC Policy Training Meeting April 30 – May 2, 2019 Interested in becoming a DPAC Champion and advocating on Capitol Hill in D.C.? Click Here to Learn EVENTS ReadMore »
FORCED NON-MEDICAL SWITCHING AND WHY IT'S HURTING PEOPLE Christopher G. Parkin is President of CGParkin Communications, Inc., a consulting firm that specializes in diabetes education development. During the past 30 years, Chris has authored numerous articles on diabetes technology and management and has assisted several medical organizations in the development of clinical practice guidelines, position statements and consensus conference reports ANTHEM RESPONDS TO #DIABETESACCESSMATTERS Anthem, a top insurance provider, responds to the #DiabetesAccessMatters campaign and shares their insights on CGM andpump coverage.
WHY I ADVOCATE: MOIRA MCCARTHY STANFORD We asked our Patient Advisory Board members to share why they advocate, and what makes them passionate about diabetes advocacy. Moira McCarthy shared a memory of her daughter when she was young, and how that memory still motivates Moira to this day.Skip to content
Facebook __ Twitter __Instagram __
Linkedin __
* HOME
* ACT NOW__
* FEDERAL ACTIONS
* STATE ACTIONS
* EXPLORE__
* HOW TO ADVOCATE
* HOT ISSUES
* DPAC STATEMENTS
* PROGRAMS__
* AFFORDABLE INSULIN PROJECT * DPAC POLICY TRAINING MEETING* DPAC CHAMPIONS
* RESOURCES
* BLOG
* ABOUT__
* FAQ
* LEADERSHIP
* PATIENT ADVISORY COUNCIL* CONTACT US
__ Menu
* HOME
* ACT NOW__
* FEDERAL ACTIONS
* STATE ACTIONS
* EXPLORE__
* HOW TO ADVOCATE
* HOT ISSUES
* DPAC STATEMENTS
* PROGRAMS__
* AFFORDABLE INSULIN PROJECT * DPAC POLICY TRAINING MEETING* DPAC CHAMPIONS
* RESOURCES
* BLOG
* ABOUT__
* FAQ
* LEADERSHIP
* PATIENT ADVISORY COUNCIL* CONTACT US
Ask Congress to Support Diabetes Self Management Training! There are too many barriers preventing individuals diagnosed with diabetes on Medicare from accessing needed training. This bill will help remove these barriers!Click Here
Is your representative a member of the Congressional Diabetes Caucus? Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click Here
Advocate for insulin exemption from your high deductible health plan.Click Here
Access to Lifesaving Medications Act (ALMA) State model legislation now available to offer patient centered transparency bills to state legislatures, providing financial relief to people with diabetes. Click Here to Learn More Ask Indiana Assembly to Support SB 255 DPAC joined 10 other national diabetes organizations urging Indiana lawmakers to improve emergency insulin access by repealing the state's prescription requirement for human insulins. Indiana is the only state that currently prohibits over-the-counter sales of Reli-On, Novolin, and Humulin. Health Committee Chair Ed Charbonneau introduced SB 255 to repeal the prescription requirement. CLICK HERE TO CALL THEM AND SHOW YOUR SUPPORT! Ask Congress to Support Diabetes Self Management Training! There are too many barriers preventing individuals diagnosed with diabetes on Medicare from accessing needed training. This bill will help remove these barriers!Click Here
Is your representative a member of the Congressional Diabetes Caucus? Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click Here
Advocate for insulin exemption from your high deductible health plan.Click Here
Access to Lifesaving Medications Act (ALMA) State model legislation now available to offer patient centered transparency bills to state legislatures, providing financial relief to people with diabetes. Click Here to Learn More Ask Indiana Assembly to Support SB 255 DPAC joined 10 other national diabetes organizations urging Indiana lawmakers to improve emergency insulin access by repealing the state's prescription requirement for human insulins. Indiana is the only state that currently prohibits over-the-counter sales of Reli-On, Novolin, and Humulin. Health Committee Chair Ed Charbonneau introduced SB 255 to repeal the prescription requirement. CLICK HERE TO CALL THEM AND SHOW YOUR SUPPORT! Ask Congress to Support Diabetes Self Management Training! There are too many barriers preventing individuals diagnosed with diabetes on Medicare from accessing needed training. This bill will help remove these barriers!Click Here
Is your representative a member of the Congressional Diabetes Caucus? Send a message of thanks or an invitation to join the largest health caucus in Congress. They need to hear from us in order to take action!Click Here
Advocate for insulin exemption from your high deductible health plan.Click Here
Access to Lifesaving Medications Act (ALMA) State model legislation now available to offer patient centered transparency bills to state legislatures, providing financial relief to people with diabetes. Click Here to Learn More Ask Indiana Assembly to Support SB 255 DPAC joined 10 other national diabetes organizations urging Indiana lawmakers to improve emergency insulin access by repealing the state's prescription requirement for human insulins. Indiana is the only state that currently prohibits over-the-counter sales of Reli-On, Novolin, and Humulin. Health Committee Chair Ed Charbonneau introduced SB 255 to repeal the prescription requirement. CLICK HERE TO CALL THEM AND SHOW YOUR SUPPORT!__ Previous
__ Next
THE POLICY ISSUES IMPACTING USFEDERAL ISSUES
Take action of federal issues impacting our communityClick Here
HOT ISSUES
These issues impact all of us in some way. Learn more here.Click Here
STATE ISSUES
Take action on diabetes issues impacting your stateClick Here
HOW YOU CAN HELP OUR COMMUNITYTOOLS
We give you the tools to be an effective policy advocateClick Here
PROGRAMS
Learn how you can get involved with DPACClick Here
RESOURCES
Helpful community links for safety, quality, and accessClick Here
THE LATEST NEWS
JULIE BABBAGE APPOINTED NEW DPAC CEO December 9, 2019 No Comments Read More » NEW YORKERS COULD BAN ACCUMULATOR ADJUSTMENT PROGRAMS! June 21, 2019 No Comments Read More » PENNSYLVANIANS! IT’S TIME TO BAN ACCUMULATOR ADJUSTMENT PROGRAMS! June 20, 2019 No Comments Read More »__ Previous
__ Next
WHO IS DPAC?
Who we serve and how we help our communityClick Here
GET THE DPAC NEWSLETTER Important issues impacting the diabetes community can happen anytime. Keep up to date and get easy ways to take action. We do not rent or sell your email addresses. Ever.__ Subscribe Now
ACT NOW
* Federal Issues
* State Issues
* DPAC Mobile App
* DPAC Newsletter
EXPLORE
* How to Advocate
* Hot Issues
* DPAC Statements
* Events
PROGRAMS
* Affordable Insulin Project * DPAC Policy Training Meetings* DPAC Champions
* Resources
ABOUT
* Why DPAC
* Leadership
* Patient Advisory Council* Contact
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0